1088 – Impact of Rapid HIV Testing and Self-Testing on Lenacapavir Effectiveness and Resistance in Thailand
Background The World Health Organization (WHO) recommends twice-yearly lenacapavir as long-acting pre-exposure prophylaxis (PrEP), offering an alternative to oral PrEP. WHO advises using rapid and self-administered HIV tests with long-acting PrEP and emphasizes flexible testing to avoid limiting access. Rapid tests have reduced sensitivity, particularly during the acute stage of infection. Starting lenacapavir during undiagnosed…